Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05407129 · ClinicalTrials.gov registry record · NA

Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

A NA study of Quality Improvement and Patient Safety, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
656
Enrollment target
1
Study location

NCT05407129: Recruiting NA study of Quality Improvement and Patient Safety, sponsored by Boston Children's Hospital.

NCT05407129 is a NA study of Quality Improvement and Patient Safety that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 656 participants, below the 1,263-participant average among 7 other Quality Improvement trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05407129, a NA study of Quality Improvement and Patient Safety, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
656 participants
Enrollment target
1
Study location

Study Summary

Hospitals ineffectively examine the safety of their processes by relying on voluntary incident reporting (VIR) by clinical staff who are overworked and afraid to report. VIR captures only 1-10% of events, excludes patients and families, and underdetects events in vulnerable groups like patients with language barriers. Patients and families are vigilant partners in care who are adept at identifying errors and AEs. Failing to actively include patients and families in safety reporting and instead relying on flawed VIR presents an important missed opportunity to improve safety. To improve hospital safety, there is a critical need to coproduce (create in partnership with families) effective systems to identify uncaptured errors. Without this information, hospitals are impeded in their ability to improve patient safety. In partnership with diverse families, nurses, physicians, and hospital leaders, investigators created a multicomponent communication intervention to engage families of hospitalized children in safety reporting. The intervention includes 3 elements: (1) a multilingual mobile (email, text, and QR-code) reporting tool prompting families to share concerns and suggestions about safety, (2) family/staff education, and (3) a process for sharing family reports with the unit and hospital so systemic issues can be addressed.

Primary Outcome

Investigators will evaluate rates and types of errors detected through the mobile tool and through voluntary incident reporting (VIR). Errors will be validated by physician and chart review in real time using an established process the study team has used in prior studies.

Interventions

  • BEHAVIORAL Family safety reporting intervention

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 656 participants
Start Date 2023-04-13
Est. Completion 2028-10-28
Phase NA
Boston Children's Hospital

462 total trials

What NCT05407129 shows while recruiting

NCT05407129 is an interventional study that assigns participants to a tested intervention. The registered 656 participants enrollment target is mid-sized for trials with a published cap, below the 1,263-participant average among 7 other Quality Improvement trials with a reported enrollment target (48% lower).

The record links to 6 conditions, with Quality Improvement appearing as the primary indexed condition, and to 1 intervention - of which Family safety reporting intervention is the first listed.

NCT05407129 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05407129 about?

NCT05407129 is a clinical study titled "Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences". Hospitals ineffectively examine the safety of their processes by relying on voluntary incident reporting (VIR) by clinical staff who are overworked and afraid to report. VIR captures only 1-10% of events, excludes patients and families, and underdetects events in vulnerable groups like patients with...

What is the current status of trial NCT05407129?

This trial is currently recruiting. It is a NA study. The enrollment target is 656 participants. The study started on 2023-04-13. Estimated completion is 2028-10-28.

What conditions does trial NCT05407129 study?

This clinical trial studies the following conditions: Quality Improvement, Patient Safety, Health Disparities, Family Reported Errors and Adverse Events, Family Safety Reporting.

What interventions are being tested in trial NCT05407129?

The interventions under investigation include: Family safety reporting intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05407129?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05407129 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality Improvement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06127199 · 656 participants · NA

    Contraceptive Efficacy Study of Ovaprene

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • NCT05338697 · 657 participants

    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  • NCT07145515 · 655 participants · NA

    Enhancing Heart Allograft Function With the OCS Heart System Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05407129, the US trial registry maintained by the National Library of Medicine. NCT05407129 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.